From natalizumab to fingolimod in eight weeks — Immunological, clinical, and radiological data in quest of the optimal switch
Autor: | Harrer, Andrea, Pilz, Georg, Oppermann, Katrin, Sageder, Marlene, Afazel, Shahrzad, Haschke-Becher, Elisabeth, Rispens, Theo, de Vries, Annick, McCoy, Mark, Stevanovic, Vlado, Hitzl, Wolfgang, Trinka, Eugen, Kraus, Jörg, Sellner, Johann, Wipfler, Peter |
---|---|
Zdroj: | In Clinical Immunology March 2017 176:87-93 |
Databáze: | ScienceDirect |
Externí odkaz: |